© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Product Name: Ulinastatin
Chemical Formula: C31H52N8O15S
Trade Names: Urinary Trypsin Inhibitor, UTI
CAS Number: 80496-13-3
Molecular Weight: 726.84 g/mol
Intended Use: Pharmaceutical, medical laboratory, clinical trial substances
Manufacturer: Details available on request, standard manufacturing by pharmaceutical suppliers
Contact Numbers: Emergency and information lines specific to regional suppliers
Recommended Use: Use in prescription-only hospital or research settings
Classification: Not classified as hazardous under OSHA or GHS
Signal Word: None required
Label Elements: No mandatory pictogram
Potential Health Effects: Possible allergic reactions, irritation if inhaled or contacted with eyes, accidental injection risk
Routes of Exposure: Inhalation, skin or eye contact, accidental ingestion
Target Organs: Respiratory tract, skin, eyes
Symptoms of Overexposure: Rash, redness of eyes or skin, respiratory discomfort, rare systemic reactions
Precautionary Statements: Wash hands thoroughly after handling, avoid breathing dust or powder
Chemical Name: Ulinastatin
Purity: ≥98% by standard pharmacopeia analysis
Impurities: Trace solvents, mixture of carrier excipients as stabilizer, not anticipated to induce clinical effects
Additives: Sterile saline, buffers, reconstitution agents in some commercial formulations
Origin: Protein derived from human urine, recombinant sources available for certain markets
Physical Form: Lyophilized powder, sterile liquid ampoules for hospital use
Inhalation: Remove person to fresh air, maintain breathing, seek medical attention if symptoms persist
Skin Contact: Wash thoroughly with soap and water for at least 15 minutes, remove contaminated clothing
Eye Contact: Rinse immediately with plenty of flowing water for several minutes, check for ongoing irritation, consult with healthcare professional
Ingestion: Rinse mouth, do not induce vomiting, send patient to hospital or poison control center immediately
Special Instructions: Show physician MSDS, monitor for symptoms of hypersensitivity or respiratory compromise
Suitable Extinguishing Media: Use CO2, foam, dry chemicals, or water spray for surrounding fire
Specific Hazards: Product does not burn easily, may emit nitrogen oxides or sulfur oxides under fire
Protective Equipment: Wear full protective firesuit and self-contained breathing apparatus
Firefighting Instructions: Isolate fire area, prevent runoff into drains, evacuate unnecessary personnel
Combustion Products: Possible toxic fumes of carbon monoxide, nitrogen oxides, sulfur compounds
Personal Precautions: Use appropriate PPE including gloves, goggles, lab coat, avoid contact with skin or eyes
Environmental Precautions: Contain spilled material, prevent release to sewers, surface waters, or soil
Spill Cleanup Methods: Collect powder or liquid using damp disposable towels, transfer to closed container for disposal
Decontamination: Clean area with detergent and water, ventilate to remove possible aerosols
Waste Disposal: According to federal, state, and local regulations, incinerate or dispose with licensed chemical waste contractors
Handling: Handle using safe laboratory practices, avoid dust generation, minimize direct handling
Engineering Controls: Work in fume hood or well-ventilated area
Storage Conditions: Store in tightly closed original container, keep at recommended temperature (usually 2–8°C unless otherwise indicated)
Incompatibilities: Do not store near strong oxidizers, acids, or bases, protect from direct sunlight or heat
Safe Transfer: Use dedicated tools, do not use common lab utensils to minimize contamination risk
Engineering Controls: Work under fume hood or local exhaust as primary containment
Personal Protective Equipment: Lab gloves (nitrile or latex), protective safety goggles, disposable lab coat
Respiratory Protection: NIOSH-approved particulate filtering mask during powder handling or spill cleanup
Hygiene Measures: Wash hands before breaks and at end of work session, do not eat or drink in work area
Exposure Limits: No occupational exposure limit established for Ulinastatin by OSHA or ACGIH
Environmental Exposure: Minimize generation of dust, use spill control protocols
Appearance: White to off-white lyophilized powder or clear liquid (reconstituted, commercial vials)
Odor: Odorless
pH (in solution): 5.5–7.5 (aqueous reconstitution)
Solubility: Soluble in water, insoluble in organic solvents
Melting/Boiling Point: Protein structure denatures above 60°C, not relevant for normal use
Vapor Pressure: Not applicable
Bulk Density: Not documented
Partition Coefficient: Not applicable (biological protein)
Viscosity: Not applicable for lyophilized powder, near water viscosity in solution
Flash Point: Not flammable
Chemical Stability: Stable under recommended storage and handling conditions
Polymerization: Not expected to occur
Conditions to Avoid: Extreme heat, direct sunlight, exposure to strong acids or alkaline materials
Incompatible Materials: Strong oxidizing agents, reducing agents, acids, bases
Decomposition Products: Thermal breakdown may produce CO2, nitrogen oxides, sulfur dioxide
Reactivity: No evidence of hazardous reactivity under normal use
Acute Toxicity: Not classified as toxic, low systemic toxicity in animal testing
LD50 (Oral, Rat): Not reported above threshold limits for protein drugs
Inhalation: Not a common route, low risk except for hypersensitivity reactions
Skin/Eye Contact: Non-irritant in normal laboratory exposure, risk with prolonged or repeated contact
Chronic Effects: No reports of long-term toxicity in occupational settings
Sensitization: Rare cases documented, possible allergic responses in sensitized individuals
Mutagenicity/Carcinogenicity: Not known to be mutagenic or carcinogenic
Ecotoxicity: Not expected to bioaccumulate or cause adverse environment effects at laboratory or medical concentrations
Mobility: Water-soluble, expected to dilute readily, no significant soil absorption
Persistence: Degrades by natural biological breakdown, protein structure short-lived in the environment
Bioaccumulation: No evidence for accumulation in aquatic or terrestrial organisms
Aquatic Toxicity: No measurable toxicity to fish, daphnia, or algae at pharmaceutical discharge concentrations
Other Hazards: None expected outside accidental large-volume spillage
Waste Disposal Methods: Dispose of as pharmaceutical or biomedical waste, conforming to local authority regulations
Container Disposal: Triple-rinse vials and discard or incinerate per institutional policy
Avoid Release: Do not let product reach surface water or municipal sewage system in concentrated amounts
Recommendation: Use licensed waste disposal contractors familiar with protein drug waste
UN Number: Not regulated as a hazardous material
Proper Shipping Name: Ulinastatin, protein drug, not otherwise specified
Transport Hazard Class: Non-hazardous under ADR, RID, IATA, IMDG regulations
Packing Group: Not applicable
Special Precautions: Ship in original packaging with cold chain as indicated for medical cold-storage product
Transport Labeling: No special hazard labeling required, verify integrity of packaging
OSHA: Not regulated as hazardous occupational material
TSCA: Not listed as chemical substance
GHS: No hazard classification for pharmaceutical protein products
FDA: Approved for therapeutic use in certain countries based on clinical data
EU Regulations: Regulated as a medicinal product under EMA guidelines
Other National/Local Laws: Comply with all regional pharmaceutical control laws, workplace health rules, and waste management standards
Training: Provide safety training to all handling personnel, keep MSDS available in work areas
